Category Europe

Survey Analyzes Tech, Media, Telecom Disputes; IP Prominent

Newly released results of a survey published by the Queen Mary University of London on disputes relating to technology, media and telecommunications reveal interesting details about the types of disputes brought and the reasons behind them.

EU Study Recommends FRAND Clarification, More Coordination On 5G

The rapid development of information and communication technologies, and the need for greater interconnectivity driven by the Internet of Things has created a variety of standard-essential patent (SEP) owners and implementers with different business models, and for more diverse licensing practices, the European Commission Joint Research Centre says in a new study. This has made it harder to agree on an interpretation of FRAND licensing principles, something European policymakers must clarify in order to meet key digital single market and other goals, it says.

WEF Davos: Responsible Leadership, Fourth Industrial Revolution, Social Responsibility

Days away from the opening of the annual World Economic Forum in Davos, the founder of the forum described the main themes of the upcoming event, and underlined the role of social responsibility for business leaders.

Research Groups Seek Stronger Protections In EU Copyright Reform Proposal

European lawmakers should boost protections for researchers and educators in the European Commission proposal for a directive on copyright in the digital single market, five research organisations said today. Among other things, lawmakers and policymakers must rethink the provisions on text and data mining as well as the exception for use of works in digital and cross-border teaching, they said.

Expensive Medicines Increase The Pressure

When Gilead brought its new antiviral medicine – Sovaldi – for the treatment of Hepatitis C to the US market for USD 84,000, it triggered a storm of protest. Demand for this revolutionary treatment was so high that the price (despite reductions) became an enormous burden on the American healthcare system. Although the product is cheaper in Switzerland at CHF 48 307, treatment is rationed for reasons of cost.

IP World Enters New Year With Major Shift Of People In Pharma, Copyright

As a new year dawns, a lot of movement has been observed in the pharmaceutical industry with new key players taking the lead. Meanwhile, new delegates are covering IP issues in Geneva, and coordination of regional groups at the World Intellectual Property Organization makes its usual yearly shift for 2017. The copyright industry also saw major changes, and law offices have been busy hiring new partners.

ECJ Advocate General Says EU Commission Cannot Make Trade Deals Without Member States

Not all parts of the European Union-Singapore trade agreement "fall within the EU’s exclusive competence and therefore the agreement cannot be concluded without the participation of all of the Member States." This is the result of an opinion of the European Court of Justice Advocate General Eleanor Sharpston published today.

No Deal: German Universities Prepare For Cut-Off From Elsevier Journals

After licensing negotiations between German university libraries and Elsevier failed at the beginning of the month, over 60 university libraries in Germany are preparing to be cut off from hundreds of journals of the British-Dutch publisher, after a standoff over pricing and access.

Southeast Asian Countries Launch IP Cooperation Plan To Be Assisted By WIPO, EU

BANGKOK – Countries in Southeast Asia have launched a 10-year action plan to strengthen their intellectual property rights cooperation, with the European Union and the World Intellectual Property Organization providing financial and technical assistance in helping the countries to achieve their goals.